CAS 956154-63-5

TCS HDAC6 20b

CAS : 956154-63-5

TCS HDAC6 20b

Degré de pureté : ≥98%

Masse moléculaire : 480.7g/mol

Ref: 54-BUP11664

TCS HDAC6 20b

CAS : 956154-63-5

TCS HDAC6 20b is a histone deacetylase (HDAC) inhibitor that is used in the treatment of chronic obstructive pulmonary disease. TCS HDAC6 20b inhibits HDAC activity and acetylation of histones, leading to changes in chromatin structure and gene expression. It is also used for the treatment of silicosis, collagen diseases, and cancer. TCS HDAC6 20b has been shown to increase the production of growth factors such as erythropoietin in mammalian cells. This drug also reduces DNA methylation by inhibiting the enzyme DNA methyltransferase.

Formule : C₂₆H₄₄N₂O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 480.7 g/mol

Ref: 3D-GNB15463

TCS HDAC6 20b

CAS : 956154-63-5

TCS HDAC6 20b (HDAC6-IN-7) is an HDAC6 inhibitor that blocks the growth of breast cancer cells and can be used in cancer research.

Formule : C₂₆H₄₄N₂O₄S

Degré de pureté : >99.99%

Couleur et forme : Solid

Masse moléculaire : 480.7

Ref: TM-T22159